[
  {
    "ts": null,
    "headline": "Cirtec Medical Announces Appointment of New Chief Executive Officer",
    "summary": "BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025. Shar brings more than 25 years of global leadership experience in the medical technology sector, with a proven track record of scaling businesses, driving innovation, and building strong custom",
    "url": "https://finnhub.io/api/news?id=ce1ce719a044febc5511870e0502fc774d3d08fed5a0f0488e356630fdc0f8a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756400340,
      "headline": "Cirtec Medical Announces Appointment of New Chief Executive Officer",
      "id": 136561918,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025. Shar brings more than 25 years of global leadership experience in the medical technology sector, with a proven track record of scaling businesses, driving innovation, and building strong custom",
      "url": "https://finnhub.io/api/news?id=ce1ce719a044febc5511870e0502fc774d3d08fed5a0f0488e356630fdc0f8a0"
    }
  },
  {
    "ts": null,
    "headline": "VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up",
    "summary": "Veeva Systems' second-quarter earnings and revenues beat estimates, margins expand and raised FY26 outlook lifts shares higher.",
    "url": "https://finnhub.io/api/news?id=6a6960f3a0a8d0f938cae013fb821b20f95e7e78c46bfba7bc723ea94e53378e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756391040,
      "headline": "VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up",
      "id": 136560905,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Veeva Systems' second-quarter earnings and revenues beat estimates, margins expand and raised FY26 outlook lifts shares higher.",
      "url": "https://finnhub.io/api/news?id=6a6960f3a0a8d0f938cae013fb821b20f95e7e78c46bfba7bc723ea94e53378e"
    }
  },
  {
    "ts": null,
    "headline": "DGX Stock Gains Following a New Joint Venture With Corewell Health",
    "summary": "Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.",
    "url": "https://finnhub.io/api/news?id=23078d4c06f5a90673baf85e3ce5baa8d817bbe959282c89a901a471090e6e88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756385400,
      "headline": "DGX Stock Gains Following a New Joint Venture With Corewell Health",
      "id": 136557961,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.",
      "url": "https://finnhub.io/api/news?id=23078d4c06f5a90673baf85e3ce5baa8d817bbe959282c89a901a471090e6e88"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?",
    "summary": "TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.",
    "url": "https://finnhub.io/api/news?id=07e32bbd618cdcce4fc4c53b35634c4a82e646407678aa86118f48fac08b213e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756385340,
      "headline": "Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?",
      "id": 136557915,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.",
      "url": "https://finnhub.io/api/news?id=07e32bbd618cdcce4fc4c53b35634c4a82e646407678aa86118f48fac08b213e"
    }
  },
  {
    "ts": null,
    "headline": "PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down",
    "summary": "Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.",
    "url": "https://finnhub.io/api/news?id=3c74456a1ab6a03eaa81be71af83e1bc4fd45085af84a479e208d231804664f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756383240,
      "headline": "PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down",
      "id": 136557963,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.",
      "url": "https://finnhub.io/api/news?id=3c74456a1ab6a03eaa81be71af83e1bc4fd45085af84a479e208d231804664f9"
    }
  },
  {
    "ts": null,
    "headline": "Should You Add Zimmer Biomet Stock to Your Portfolio Now?",
    "summary": "ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.",
    "url": "https://finnhub.io/api/news?id=552ffe695884ab4f0944550643895908ac2630f80da91972ebc1aa23c2499205",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756383060,
      "headline": "Should You Add Zimmer Biomet Stock to Your Portfolio Now?",
      "id": 136557964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.",
      "url": "https://finnhub.io/api/news?id=552ffe695884ab4f0944550643895908ac2630f80da91972ebc1aa23c2499205"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (NYSE:BSX) shareholders have earned a 38% CAGR over the last three years",
    "summary": "It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...",
    "url": "https://finnhub.io/api/news?id=2bbb42818aa3f572e9b3563d4012db13f359580bef4932e90db9cfa7b2f282e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756378816,
      "headline": "Boston Scientific (NYSE:BSX) shareholders have earned a 38% CAGR over the last three years",
      "id": 136557965,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...",
      "url": "https://finnhub.io/api/news?id=2bbb42818aa3f572e9b3563d4012db13f359580bef4932e90db9cfa7b2f282e7"
    }
  }
]